Clinical Medical Center Osijek
- Address
- lock Available on a paid plan
Clinical Hospital Centre Osijek - Immunology & Gastroenterology Research
Clinical Hospital Centre Osijek is a distinguished medical research institution conducting pivotal clinical trials across multiple therapeutic areas. The center demonstrates particular expertise in autoimmune disorders and pediatric gastroenterology, contributing to the advancement of novel therapeutic interventions for complex medical conditions.
- Neurological autoimmune diseases: Phase 1/3 biosimilar studies in relapsing-remitting multiple sclerosis, evaluating pharmacokinetics and therapeutic efficacy
- Systemic autoimmune conditions: Long-term safety and efficacy trials for moderate to severe systemic lupus erythematosus using novel oral treatments
- Pediatric gastroenterology: Phase 2 dose-finding studies for functional constipation in infants and young children
The center's research portfolio reflects a commitment to both adult and pediatric populations, with special emphasis on rare and challenging autoimmune conditions. Their participation in international multicenter trials demonstrates their capacity to conduct sophisticated comparative studies, including biosimilar equivalence trials and long-term extension studies that monitor safety profiles and sustained therapeutic responses across diverse patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 15 therapeutic areas and 15 of 126 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 126 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 17 by active trials.
lock +16 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG6trials
lock +8 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 60 other sites in Croatia
Therapeutic Area Benchmark — Croatia
Select a therapeutic area to compare against other sites in Croatia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Croatia
Market Share
Country: Croatia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinical Medical Center Osijek
lock Showing 1 of 51 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Double-blind, Randomized, Active-controlled, Parallel-group, Phase 1/3 study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients with Relapsing-remitting Multiple Sclerosis. | Celltrion Inc. | Phase III | Not Recruiting | Jan 2024 | — |
IMP list
lock Showing 1 of 126 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorescein Sodium | 5 | Unknown | 2022-12-21 | 2026-06-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.